Literature DB >> 19665983

Ethical and practical challenges surrounding genetic and genomic research in developing countries.

Aceme Nyika1.   

Abstract

The nature of some potential benefits and risks associated with genetic research is different from the types of potential benefits and risks associated with other types of health research such as clinical trials and biomedical research involving humans. Whereas most potential risks associated with biomedical research or clinical trials are mainly biological in nature, potential risks associated with genetic research are mainly of socioeconomic nature. Although the peculiarity of some of the aspects of genetic research and the complexity of the science involved are acknowledged, the extent to which these characteristics hinder firstly disclosure of information to participants and their communities and secondly comprehension of the disclosed information is a practical challenge that tends to be exaggerated in some cases. In this article, a brief overview of the various types of genetic research will be given in order to set the scene for some ethical and practical issues surrounding the research in developing countries that will be discussed subsequently. Case studies that illustrate some of the ethical and practical issues flagged will be given, followed by suggestions on possible ways of tackling some of the challenges in developing country settings. Nevertheless, genetic and genomic research could go a long way in providing knowledge that could be useful in the development of drugs and vaccines for many diseases affecting the developing countries.

Entities:  

Mesh:

Year:  2009        PMID: 19665983     DOI: 10.1016/j.actatropica.2009.07.034

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  28 in total

Review 1.  African genetic diversity and adaptation inform a precision medicine agenda.

Authors:  Luisa Pereira; Leon Mutesa; Paulina Tindana; Michèle Ramsay
Journal:  Nat Rev Genet       Date:  2021-01-11       Impact factor: 53.242

2.  Informed consent form challenges for genetic research in a developing Arab country with high risk for genetic disease.

Authors:  Satish Chandrasekhar Nair; Halah Ibrahim
Journal:  J Genet Couns       Date:  2014-09-18       Impact factor: 2.537

3.  Pharmacogenomic technologies: a necessary "luxury" for better global public health?

Authors:  Catherine Olivier; Bryn Williams-Jones
Journal:  Global Health       Date:  2011-08-24       Impact factor: 4.185

Review 4.  Community engagement in epigenomic and neurocognitive research on post-traumatic stress disorder in Rwandans exposed to the 1994 genocide against the Tutsi: lessons learned.

Authors:  Clarisse Musanabaganwa; Stefan Jansen; Agaz Wani; Alex Rugamba; Jean Mutabaruka; Eugene Rutembesa; Annette Uwineza; Segun Fatumo; Erno J Hermans; Jacob Souopgui; Derek E Wildman; Monica Uddin; Benno Roozendaal; Rose Njemini; Leon Mutesa
Journal:  Epigenomics       Date:  2022-08-25       Impact factor: 4.357

5.  Consent and community engagement in diverse research contexts.

Authors: 
Journal:  J Empir Res Hum Res Ethics       Date:  2013-10       Impact factor: 1.742

6.  Ethical issues in human genomics research in developing countries.

Authors:  Jantina de Vries; Susan J Bull; Ogobara Doumbo; Muntaser Ibrahim; Odile Mercereau-Puijalon; Dominic Kwiatkowski; Michael Parker
Journal:  BMC Med Ethics       Date:  2011-03-18       Impact factor: 2.652

7.  Ethical and legal implications of whole genome and whole exome sequencing in African populations.

Authors:  Galen E B Wright; Pieter G J Koornhof; Adebowale A Adeyemo; Nicki Tiffin
Journal:  BMC Med Ethics       Date:  2013-05-28       Impact factor: 2.652

8.  Pharmacogenetics in breast cancer: steps toward personalized medicine in breast cancer management.

Authors:  Sarah Rofaiel; Esther N Muo; Shaker A Mousa
Journal:  Pharmgenomics Pers Med       Date:  2010-09-17

9.  Seeking consent to genetic and genomic research in a rural Ghanaian setting: a qualitative study of the MalariaGEN experience.

Authors:  Paulina Tindana; Susan Bull; Lucas Amenga-Etego; Jantina de Vries; Raymond Aborigo; Kwadwo Koram; Dominic Kwiatkowski; Michael Parker
Journal:  BMC Med Ethics       Date:  2012-07-02       Impact factor: 2.652

10.  Pharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow Nation.

Authors:  Louise Warnich; Britt I Drögemöller; Michael S Pepper; Collet Dandara; Galen E B Wright
Journal:  Curr Pharmacogenomics Person Med       Date:  2011-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.